Mendel.ai

Mendel.ai

AI-driven clinical data analysis for oncology

About Mendel.ai

Simplify's Rating
Why Mendel.ai is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Rating Differentiation

Industries

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$63.6M

Headquarters

San Jose, California

Founded

2017

Overview

Mendel.ai enhances clinical data analysis in healthcare, particularly in oncology research and clinical trials, by using artificial intelligence to match cancer patients with suitable clinical trials more efficiently. The company analyzes large datasets, including electronic medical records and genetic information, allowing clients like researchers and pharmaceutical companies to gain valuable insights quickly. Unlike competitors, Mendel.ai specializes in real-world evidence and data, addressing the need for effective data analysis tools in the healthcare sector. The goal is to improve the efficiency and accuracy of clinical trials, ultimately leading to better patient outcomes.

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnerships with Google Cloud and Microsoft Azure expand Mendel.ai's customer base.
  • The AI in clinical trials market is projected to grow significantly by 2035.
  • Rising demand for RWE and RWD offers Mendel.ai opportunities to improve patient outcomes.

What critics are saying

  • Generative AI's data 'hallucinations' could harm Mendel.ai's credibility in clinical settings.
  • Competition from companies adopting Meta's Llama 3 NIM may affect market share.
  • Challenges in drug trial success rates could impact client satisfaction with Mendel.ai.

What makes Mendel.ai unique

  • Mendel.ai uses neuro-symbolic AI to address generative AI limitations in healthcare.
  • The Hypercube platform integrates with Snowflake and Azure for scalable data analysis.
  • Mendel.ai's AI tools focus on oncology, enhancing clinical trial patient matching.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$63.6M

Above

Industry Average

Funded Over

3 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$40M
Mendel.ai
$45M
Linktree
$65M
Substack
$100M
ClickUp

Benefits

Remote Work Options

Professional Development Budget

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

5%
Hit Consultant
Dec 12th, 2024
Neuro-Symbolic Ai In Healthcare: Unlocking Precision Medicine

Karim Galil, Co-Founder and Chief Executive Officer of Mendel AIUntil recently, the term “symbolic” bore negative connotations in AI because it harkened back to the failures to achieve symbolic thinking during the so-called “AI winter” of the 1980s. Since then, generative AI has demonstrated the masterly capacities of neural networks at scale.Generative AI has relieved doctors of their administrative and cognitive burdens, for example, by handling administration and paperwork, including clinical summaries. More than 70 percent of healthcare organizations are pursuing generative AI capabilities, according to McKinsey. Today, however, we see generative AI’s deficiencies, especially in medicine. It can behave like a parrot, mindlessly telling users whatever its blind algorithms have told it to say. They also “hallucinate” or invent data, unacceptably compromising care and research.AI-generated clinical summaries don’t necessarily come under FDA oversight on standards and could cause more harm than benefits, according to JAMA. These concerns are partly why large multinational technology companies have abandoned many AI-powered healthcare efforts in recent years

Hit Consultant
Sep 23rd, 2024
Mendel AI's Hypercube Platform Now Available on Snowflake, Transforming Clinical Data Analysis

To offer customers a hands-on experience, Mendel AI has launched TryMe, a trial environment accessible on its website.

Datalab
Sep 22nd, 2024
Mendel AI's Hypercube on Snowflake Revolutionizes Clinical Data Analysis

Mendel AI's Hypercube platform, integrated with Snowflake's Data Cloud, is set to redefine how clinical data analysis is approached, bringing about greater efficiency, accuracy, and new insights in the medical field.

PR Newswire
Sep 3rd, 2024
Hypercube Platform From Mendel Now Available In The Microsoft Azure Marketplace

Microsoft Azure customers worldwide now gain access to Mendel's Hypercube Platform to leverage advanced AI-driven clinical data analytics, enhancing healthcare decision-making with the scalability, reliability, and agility of Azure to drive application development and shape business strategies.SAN JOSE, Calif., Sept. 3, 2024 /PRNewswire/ -- Mendel, a leader in clinical artificial intelligence, today announced the availability of the Hypercube Platform in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. Mendel customers can now take advantage of the productive and trusted Azure cloud platform, with streamlined deployment and management.Mendel's Hypercube Platform is a comprehensive clinical data analytics solution that enables healthcare organizations to unlock insights from vast amounts of structured and unstructured data. Leveraging Mendel's proprietary AI that couples large language models with a clinical hypergraph, Hypercube transforms fragmented data into meaningful clinical insights, accelerating research and improving patient care. Leading life science companies use Hypercube for patient recruitment, patient cohort identification, chart review, and analytical queries."Our collaboration with Microsoft Azure marks a significant milestone for Mendel as we expand the accessibility of our Hypercube Platform," said Dr. Karim Galil, CEO of Mendel

PR Newswire
Aug 20th, 2024
Mendel Joins Google Cloud Partner Advantage And Delivers Hypercube Through Google Cloud Marketplace

Empowering life science organizations to unlock the power of generative AI with 100% explainability and limited hallucinationsSAN JOSE, Calif., Aug. 20, 2024 /PRNewswire/ -- Mendel announced today that it has joined Google Cloud Partner Advantage as a Partner level partner for the Build Engagement Model, giving customers the ability to access Hypercube on Google Cloud Marketplace.As a Google Cloud partner, Mendel offers healthcare and life science customers a suite of AI-powered tools designed to transform clinical data analytics workflows. Mendel's Hypercube leverages an AI platform that couples large language models with a clinical hypergraph to unlock the vast potential of clinical data warehouses, enabling life science organizations to make more informed, data-driven decisions and improve patient outcomes.Key features of Mendel's Hypercube platform include:Hypercube Cohort : Rapidly create and refine patient cohorts with 5x increase in accuracy and scale.: Rapidly create and refine patient cohorts with 5x increase in accuracy and scale. Hypercube Charts : Chat with medical records through a user-friendly interface, completing chart reviews with 30%+ more efficiency.: Chat with medical records through a user-friendly interface, completing chart reviews with 30%+ more efficiency. Hypercube Analyst : Query clinical data with a low-code interface, enabling 10x faster querying.: Query clinical data with a low-code interface, enabling 10x faster querying. Hypercube Redact: De-identify and tokenize patient records with >99% accuracy.De-identify and tokenize patient records with >99% accuracy

Recently Posted Jobs

Sign up to get curated job recommendations

Mendel.ai is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Mendel.ai's jobs every 8 hours, so check again soon! Browse all jobs →